Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Agios Pharmaceuticals Inc Is A Biopharmaceutical Company Focused On The Field Of Cellular Metabolism To Create Differentiated Medicines For Rare Diseases, With A Focus On Classical Hematology. The Company'S Primary Focus Is To Develop Potentially Transformative Small-Molecule Medicines. Its Product Candidate, Pyrukynd (Mitapivat), Is An Activator Of Both Wild-Type And Mutant Pyruvate Kinase Enzymes, Developed For The Treatment Of Hemolytic Anemias. The Other Drug Candidates In Its Pipeline Include Tebapivat (Pk Activator), Being Developed As A Potential Treatment For Mds-Associated Anemia And Sickle Cell Disease, Ag-181 (Pah Stabilizer), Ag-236 And Others.